Drug News
-
Otsuka Ventures into Psychedelic Medicines with Mindset Pharma Acquisition
Japanese pharmaceutical giant Otsuka is making a significant move into the emerging field of psychedelic medicines by acquiring Canada’s Mindset…
Read More » -
Sage Therapeutics Announces Major Restructuring Following Zurzuvae FDA Approval
Sage Therapeutics, in response to the FDA’s narrower-than-expected approval of its flagship antidepressant Zurzuvae, has announced significant changes to its…
Read More » -
Primate Antibody Treatment Prevents Organ Rejection After Transplant – Study
A recent study conducted in non-human primates has unveiled promising potential in using a manmade monoclonal antibody to address the…
Read More » -
Taking Statins Post-“Bleeding” Stroke May Help Prevent Subsequent Strokes – Study
Using statin medication to lower cholesterol levels following a hemorrhagic stroke may reduce the likelihood of experiencing a subsequent stroke…
Read More » -
World’s First Subcutaneous Cancer Injection Launched by NHS England
In a groundbreaking development, NHS England has unveiled a revolutionary approach to cancer treatment, offering hope to hundreds of cancer…
Read More » -
Teva Secures Early Launch of Generic Vivitrol After Settling Patent Case with Alkermes
In a significant legal development, Teva Pharmaceuticals has reached a settlement with Alkermes, the manufacturer of Vivitrol, a medication used…
Read More » -
Zevra Therapeutics Makes Strategic Leap into Rare Disease Market with Acer Therapeutics Acquisition
Zevra Therapeutics, a forward-looking pharmaceutical company, has taken an impressive stride toward establishing itself as a prominent player in the…
Read More » -
Johnson & Johnson Slashes Price of TB Drug in Low-Income Countries to Expand Access
Seven weeks after announcing its decision to allow generic competition for the drug-resistant tuberculosis (TB) treatment Sirturo (bedaquiline) in low-…
Read More » -
New Study Suggests Postnatal Antidepressant Use Benefits Child’s Development
In a promising revelation for new mothers grappling with postpartum depression, a recent study indicates that the use of selective…
Read More » -
Newly Approved Narcan Overdose Formulation Set to Be Available Next Week at $44.99
According to reports, Narcan, a vital medication designed to reverse opioid overdoses, is set to become readily accessible on drugstore…
Read More »